Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals

por Tsuchimine, Shoko, Yasui-Furukori, Norio, Kaneda, Ayako, Kaneko, Sunao
Publicado 2013

ABO Blood Type and Personality Traits in Healthy Japanese Subjects

por Tsuchimine, Shoko, Saruwatari, Junji, Kaneda, Ayako, Yasui-Furukori, Norio
Publicado 2015

Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders

por Saruwatari, Junji, Nakashima, Hiroo, Tsuchimine, Shoko, Nishimura, Miki, Ogusu, Naoki, Yasui-Furukori, Norio
Publicado 2014

PS105. Effects of CYP2C19 genotype on steady-state plasma concentrations of escitalopram and desmetyl metabolite in Japanese depressed patients

por Tsuchimine, Shoko, Inoue, Yoshimasa, Ochi, Shinichiro, Suzuki, Yutaro, Tajiri, Misuzu, Norio, Yasui-Furukori
Publicado 2016

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis...

por Tomita, Tetsu, Norio, Yasui-Furukori, Sato, Yasushi, Nakagami, Taku, Tsuchimine, Shoko, Kaneda, Ayako, Kaneko, Sunao
Publicado 2014

PS108. Characteristics of escitalopram discontinuation syndrome

por Norio-Furukori, Yasui, Hashimoto, Kojiro, Ishioka, Masamichi, Nakamura, Kazuhiko, Suguwara, Norio, Tomita, Tetsu, Tsuchimine, Shoko
Publicado 2016

Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression

por Tsuchimine, Shoko, Ochi, Shinichiro, Tajiri, Misuzu, Suzuki, Yutaro, Sugawara, Norio, Inoue, Yoshimasa, Yasui-Furukori, Norio
Publicado 2018

Effects of personality on the association between paroxetine plasma concentration and response

por Tomita, Tetsu, Yasui-Furukori, Norio, Nakagami, Taku, Tsuchimine, Shoko, Ishioka, Masamichi, Kaneda, Ayako, Nakamura, Kazuhiko
Publicado 2018

The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder

por Tomita, Tetsu, Yasui-Furukori, Norio, Nakagami, Taku, Tsuchimine, Shoko, Ishioka, Masamichi, Kaneda, Ayako, Sugawara, Norio, Kaneko, Sunao
Publicado 2014

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan

por Tsuruga, Koji, Sugawara, Norio, Yasui-Furukori, Norio, Takahashi, Ippei, Tsuchimine, Shoko, Kaneda, Ayako, Nakaji, Shigeyuki, Nakamura, Kazuhiko
Publicado 2014

Body composition in patients with schizophrenia: Comparison with healthy controls

por Sugawara, Norio, Yasui-Furukori, Norio, Tsuchimine, Shoko, Fujii, Akira, Sato, Yasushi, Saito, Manabu, Matsuzaka, Masashi, Takahashi, Ippei, Kaneko, Sunao
Publicado 2012

No association between dietary patterns and depressive symptoms among a community-dwelling population in Japan

por Sugawara, Norio, Yasui-Furukori, Norio, Tsuchimine, Shoko, Kaneda, Ayako, Tsuruga, Koji, Iwane, Kaori, Okubo, Noriyuki, Takahashi, Ippei, Kaneko, Sunao
Publicado 2012

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan

por Sugawara, Norio, Ishioka, Masamichi, Tsuchimine, Shoko, Tsuruga, Koji, Sato, Yasushi, Furukori, Hanako, Kudo, Shuhei, Tomita, Tetsu, Nakagami, Taku, Yasui-Furukori, Norio
Publicado 2015

MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer’s disease

por Noguchi-Shinohara, Moeko, Koike, Masato, Morise, Hirofumi, Kudo, Kiwamu, Tsuchimine, Shoko, Komatsu, Junji, Abe, Chiemi, Kitagawa, Sachiko, Ikeda, Yoshihisa, Yamada, Masahito
Publicado 2021

Reduced plasma orexin-A levels in patients with bipolar disorder

por Tsuchimine, Shoko, Hattori, Kotaro, Ota, Miho, Hidese, Shinsuke, Teraishi, Toshiya, Sasayama, Daimei, Hori, Hiroaki, Noda, Takamasa, Yoshida, Sumiko, Yoshida, Fuyuko, Kunugi, Hiroshi
Publicado 2019

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

por Aoki, Akiko, Ishiguro, Shin, Watanabe, Takashi, Ueda, Mikito, Hayashi, Yuki, Akiyama, Kazufumi, Kato, Kazuko, Inoue, Yoshimasa, Tsuchimine, Shoko, Yasui-Furukori, Norio, Shimoda, Kazutaka
Publicado 2014

Effect of age and disease on bone mass in Japanese patients with schizophrenia

por Sugawara, Norio, Yasui-Furukori, Norio, Umeda, Takashi, Tsuchimine, Shoko, Fujii, Akira, Sato, Yasushi, Saito, Manabu, Furukori, Hanako, Danjo, Kazuma, Matsuzaka, Masashi, Takahashi, Ippei, Kaneko, Sunao
Publicado 2012

PS213. Pharmacokinetics of mirtazapine and its hydroxylated metabolite in Japanese psychiatric patients treated with mirtazapine

por Watanabe, Takashi, Akiyama, Kazufumi, Aoki, Akiko, Hayashi, Yuki, Inoue, Yoshimasa, Ishiguro, Shin, Kato, Kazuko, Pierce, Jason, Shimoda, Kazutaka, Shinozaki, Masataka, Tsuchimine, Shoko, Ueda, Mikito, Yasui-Furukori, Norio
Publicado 2016

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

por Saruwatari, Junji, Yasui-Furukori, Norio, Kamihashi, Ryoko, Yoshimori, Yuki, Oniki, Kentaro, Tsuchimine, Shoko, Noai, Madoka, Sato, Yasushi, Nakagami, Taku, Sugawara, Norio, Saito, Manabu, Fujii, Akira, Kajiwara, Ayami, Mihara, Shuichi, Ogata, Yasuhiro, Kaneko, Sunao, Nakagawa, Kazuko
Publicado 2013